Access considerations for a COVID-19 vaccine for South Africa

Abstract

The novel coronavirus (COVID-19) pandemic is a defining point in human history, having far-reaching effects on all aspects of human life. In the race to find a vaccine, governments need to work collectively to ensure that any life-saving interventions are accessible and affordable to populations across the globe. This pandemic has created an opportunity for international cooperation in working on transparency issues both in terms of sharing manufacturing details to make devices for the diagnosis and treatment of COVID-19 and in terms of clinical trials for therapies that could prove to be effective against the disease.